BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26172630)

  • 1. HelpDesk answers: is it safe to add long-acting β-2 agonists to inhaled corticosteroids in patients with persistent asthma?
    Townsend L; Madlon-Kay DJ
    J Fam Pract; 2015 Jun; 64(6):370-1. PubMed ID: 26172630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
    Kimura T; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting beta-agonists in adult asthma: Evidence that these drugs are safe.
    Nelson HS
    Prim Care Respir J; 2006 Oct; 15(5):271-7. PubMed ID: 16979380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.
    Wang J; Nie B; Xiong W; Xu Y
    J Clin Pharm Ther; 2012 Apr; 37(2):204-11. PubMed ID: 21740451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC; Hurst MM
    Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long and short of beta2-agonists.
    Lötvall J
    Pulm Pharmacol Ther; 2002; 15(6):497-501. PubMed ID: 12493336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy.
    Weatherall M; Wijesinghe M; Perrin K; Harwood M; Beasley R
    Thorax; 2010 Jan; 65(1):39-43. PubMed ID: 20029037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of β2-Agonists in Asthma: Linking Mechanisms, Meta-Analyses and Regulatory Practice.
    Dissanayake SB
    AAPS J; 2015 May; 17(3):754-7. PubMed ID: 25712726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LABAs in asthmatic children: highlights and new inside.
    Miraglia del Giudice M; Matera MG; Capristo C; Conte M; Santaniello F; Chinellato I; Leonardi S; Miraglia del Giudice MC; Perrone L
    Pulm Pharmacol Ther; 2013 Oct; 26(5):540-3. PubMed ID: 23583567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
    Tamm M; Richards DH; Beghé B; Fabbri L
    Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budesonide/formoterol in the treatment of asthma.
    Hodgson D; Mortimer K; Harrison T
    Expert Rev Respir Med; 2010 Oct; 4(5):557-66. PubMed ID: 20923335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of inhaled tiotropium in asthma, uncontrolled with standard combination therapy.
    Antoniu SA; Antohe I
    Expert Opin Pharmacother; 2013 May; 14(7):967-9. PubMed ID: 23514606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma].
    Kardos P; Berdel D; Buhl R; Criée CP; Freihorst J; Gillissen A; Karg O; Pfeifer M; Magnussen H; Rabe KF; Teschler H; Vogelmeier C; Welte T; Wettengel R; Worth H
    Pneumologie; 2010 Jun; 64(6):333-5. PubMed ID: 20533125
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
    Prenner BM
    Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
    Naedele-Risha R; Dorinsky P; Craig TJ
    J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergics for treatment of asthma.
    Quirce S; Domínguez-Ortega J; Barranco P
    J Investig Allergol Clin Immunol; 2015; 25(2):84-93; quiz 94-5. PubMed ID: 25997301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence based answers--is salmeterol safe in asthma?
    Spurling G; Doust J
    Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
    [No Abstract]   [Full Text] [Related]  

  • 19. Safe use of long-acting β-agonists: what have we learnt?
    Sears MR
    Expert Opin Drug Saf; 2011 Sep; 10(5):767-78. PubMed ID: 21521133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy.
    Cossette B; Beauchesne MF; Forget A; Lemière C; Larivée P; Rey E; Blais L
    Ann Allergy Asthma Immunol; 2014 May; 112(5):459-64. PubMed ID: 24656659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.